Literature DB >> 35891739

Imipenem Resistance in Gram-Negative Bacteria in the Central Pediatric Teaching Hospital in Baghdad, Iraq.

H Sahib Abdul-Mohammed1, A Kamal Mohammed2, Z Mohsen Ahmed2.   

Abstract

Antimicrobial resistance (AMR) is a serious challenge for infectious disease prevention and treatment, according to the World Health Organization. It is a worldwide problem caused primarily by inappropriate and insufficient therapy, misuse of antimicrobials without physician supervision, unnecessary hospital readmissions, and other factors. AMR has several consequences, including increased medical costs and mortality. The present study aimed to evaluate imipenem resistance in gram-negative bacteria in Central Pediatric Teaching Hospital in Baghdad, Iraq, and determine this bacteria resistance in different samples. Initially, a total of 100 different samples were collected from child patients from October 1, 2020, to August 31, 2021. Each isolate was identified using VITEK 2 automated microbiology system. The recorded data showed that the isolated organisms resistant to imipenem included Klebsiella pneumonia (n=21), Pseudomonas aeruginosa (n=19), and Acinetobacter baumannii (n=16). In the current study, Klebsiella pneumonia was the most common pathogen in males (n=57) compared to female (n=43), followed by Pseudomonas aeruginosa and Acinetobacter baumannii, particularly in the age range of 1 day- 3 years. Depending on the sample type, Klebsiella pneumonia, the most imipenem-resistant bacteria, was found more in the urine of patients with urinary tract infections. Pseudomonas aeruginosa was equally found in blood, urine, wound swab, and sputum samples. In comparison to other samples, Acinetobacter baumannii was found in greater numbers in the blood and in an equal number in urine and cerebrospinal.

Entities:  

Keywords:  Children; Different samples; Gram-negative bacteria; Imipenem antibiotic

Mesh:

Substances:

Year:  2022        PMID: 35891739      PMCID: PMC9288647          DOI: 10.22092/ARI.2021.356678.1891

Source DB:  PubMed          Journal:  Arch Razi Inst        ISSN: 0365-3439


  24 in total

1.  In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme.

Authors:  James A Karlowsky; Sibylle H Lob; Krystyna M Kazmierczak; Stephen P Hawser; Sophie Magnet; Katherine Young; Mary R Motyl; Daniel F Sahm
Journal:  J Antimicrob Chemother       Date:  2018-07-01       Impact factor: 5.790

2.  Clinical outcomes of Enterobacteriaceae infections stratified by carbapenem MICs.

Authors:  Twisha S Patel; Jerod L Nagel
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

3.  Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.

Authors:  Timothy R Walsh; Janis Weeks; David M Livermore; Mark A Toleman
Journal:  Lancet Infect Dis       Date:  2011-04-07       Impact factor: 25.071

Review 4.  Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

Authors:  R E Hancock
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

5.  The costs of nosocomial resistant gram negative intensive care unit infections among patients with the systemic inflammatory response syndrome- a propensity matched case control study.

Authors:  Anupama Vasudevan; Babar Irfan Memon; Amartya Mukhopadhyay; Jialiang Li; Paul Ananth Tambyah
Journal:  Antimicrob Resist Infect Control       Date:  2015-02-02       Impact factor: 4.887

Review 6.  Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  Sirijan Santajit; Nitaya Indrawattana
Journal:  Biomed Res Int       Date:  2016-05-05       Impact factor: 3.411

7.  Patterns of antimicrobial resistance in intensive care unit patients: a study in Vietnam.

Authors:  Giang M Tran; Thao P Ho-Le; Duc T Ha; Chau H Tran-Nguyen; Tuyet S M Nguyen; Thao T N Pham; Tuyet A Nguyen; Dung A Nguyen; Hoa Q Hoang; Ngoc V Tran; Tuan V Nguyen
Journal:  BMC Infect Dis       Date:  2017-06-15       Impact factor: 3.090

8.  Imipenem Resistance among Gram-Negative and Gram-Positive Bacteria in Hospitalized Patients.

Authors:  A Khorshidi; Ar Sharif
Journal:  Iran J Public Health       Date:  2010-06-30       Impact factor: 1.429

9.  Mechanisms of antimicrobial resistance in Gram-negative bacilli.

Authors:  Étienne Ruppé; Paul-Louis Woerther; François Barbier
Journal:  Ann Intensive Care       Date:  2015-08-12       Impact factor: 6.925

10.  High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.

Authors:  Andrés H Uc-Cachón; Carlos Gracida-Osorno; Iván G Luna-Chi; Jonathan G Jiménez-Guillermo; Gloria M Molina-Salinas
Journal:  Medicina (Kaunas)       Date:  2019-09-13       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.